Exercising Stock Options

How exercising changes an option into shares

An employee stock option gives the holder the right, but not the obligation, to buy a specified number of company shares at the agreed exercise price. Exercising that right acquires the corresponding shares once the exercise is completed under the grant terms. It does not automatically cash out the award, authorize a sale, or settle every tax question.

Grant, vesting, exercise, and sale

For a grant that requires vesting before exercise, the four stages have different effects:

Stage	What the holder has	What usually happens
Grant	A contractual right under the option agreement	The company sets the quantity, exercise price, vesting conditions, expiry, and other terms
Vesting	Some or all of those options become exercisable under the stated time or performance conditions	Vesting makes options eligible to exercise; it does not automatically deliver shares or cash
Exercise	The holder chooses whether to use an eligible option	The holder pays the exercise price and acquires the corresponding shares once the plan’s exercise and issuance requirements are met
Sale	The holder owns the acquired shares, subject to any transfer restrictions	A permitted buyer may purchase some or all shares, producing sale proceeds

This separation is why a vested option is not the same as a share. Suppose a hypothetical grant contains 1,000 options with 25% annual vesting. After the first annual vesting point, 250 options may be exercisable, assuming no other conditions apply. The holder still has not received 250 shares or any cash merely because those options vested. If the holder exercises all 250, those options are consumed and the corresponding shares are issued under the plan. The remaining 750 options stay outstanding, subject to future vesting and expiry.

Where the agreement permits partial exercise, the holder can use only the portion selected. Exercising 250 of 1,000 options does not consume the other 750 or make them exercisable early. Each exercised option is spent: it cannot be used again to acquire another share. Exercise itself does not guarantee that the resulting shares can be sold immediately. Sale may require administrator approval, a trading window, a tender offer, another permitted transfer mechanism, or compliance with securities and company restrictions.

Vesting does not itself trigger an exercise payment. The actual plan controls whether the holder must initiate exercise or an automatic expiry procedure may apply. For example, the NIKE 2025 incentive plan, §7(c)(iii), permits the committee to arrange automatic exercise of eligible unexercised options immediately before expiry only when fair market value exceeds the exercise price, using net exercise for the price and required withholding. This is a plan-specific possibility, not a rule for other grants. The holder should confirm the actual notice, approval, funding and deadline procedures. A completed exercise and a sale are separate transactions: exercise creates the shareholding, while sale converts some or all of that holding into cash if a permitted transfer path exists. The SEC Investor.gov overview of employee stock option plans describes this basic distinction between the award, vesting, exercise and ownership.

Before applying this lifecycle, confirm that the award really is a share-purchase option. A direct stock award delivers shares under its own conditions. An RSU may settle in shares or cash, or may become payable when its service or performance conditions are met. An employee share purchase plan governs purchases made through that program, while a cash-only virtual award promises a cash payment rather than delivery of company shares. Similar names do not make their exercise, ownership or tax mechanics interchangeable. The actual agreement and award documents determine which mechanism applies. For wider context on how conditional equity differs from cash compensation, see Compensation Package.

Caption: Conceptual employee share-option routes. Early exercise requires express permission; purchased shares may remain unvested and subject to repurchase. Exercise and share issuance do not guarantee that a sale is allowed. SEC Investor.gov: Employee Stock Option Plans · NIKE: 2025 incentive plan, Annex A · Newsmax: 2025 option agreement, Early Exercise Rider

Employee stock options versus exchange-traded options

Employee stock options and exchange-traded calls can appear similar because both give someone the right to acquire shares at a stated price. Their transactions are different. An employee option is a company-awarded purchase right governed by the grant, plan and administrator. An exchange-traded option is a standardized contract bought or sold through a brokerage account.

For a physically settled exchange-traded call, the holder exercises the contract to buy the underlying shares. For a put, the holder exercises to sell the underlying shares. Assignment imposes the corresponding obligation on the option writer. By contrast, selling or closing a traded option transfers or ends the option position without the seller exercising it to acquire or deliver shares.

That distinction affects value. A traded option can contain time value, so selling the contract before exercise may realize some or all of that value. An employee purchase right is not a trading contract with a market premium, and its value cannot be transferred merely because a traded option could be sold. Transferability depends on the employee award’s terms; many company grants restrict it. The Options Industry Council’s explanation of exercising options explains the holder-exercise and writer-assignment mechanics for standardized traded contracts.

Consider two limited examples:

• A trader buys a listed call with the right to buy the underlying shares in the quantity specified by the contract at its strike price. Later, the trader either exercises that right, sells the call before exercise, or lets it expire according to the brokerage account’s rules.
• An employee receives a grant to buy 1,000 company shares at a $2 exercise price. The employee can exercise an eligible portion, but only under the company’s vesting, approval, funding and expiry rules. Unless those rules permit a transfer, the employee cannot treat the grant like a listed call that can be sold in the market.

“American-style” and “European-style” describe when a traded contract may be exercised. They do not identify an employee’s country or determine U.S., U.K., German or other employee tax treatment. Broker cutoffs, exercise-by-exception processing, automatic-exercise instructions, contract multipliers and margin requirements also belong to the particular trading contract and account. They should not be transferred to an employee grant.

The same boundary applies to expiry. A broker may process an expiring traded position according to the account’s instructions, but an employee option does not necessarily exercise automatically or settle for cash. The holder must use the employee plan’s process and meet its actual deadline. For the distinctions between exercising a traded option and exercising a company grant, see the OIC exercise FAQ.

When stock options can be exercised

Vesting, expiry, and company restrictions

You may exercise only the options that are eligible under the grant, plan and company procedures at the time you act. That eligible quantity can be narrower than the total grant, and an exercisable balance does not by itself authorize every related action.

Consider a hypothetical grant of 1,000 options that vests 25% each year. After the first annual vesting point, 250 options are vested and potentially exercisable, assuming no performance condition, amendment or other restriction applies. Vesting changes the options’ status; it does not give you 250 shares or cash. You acquire shares only by exercising and completing the settlement process.

Several dates can govern the exercise right:

• The grant date establishes when the award was made and starts the contractual period.
• Vesting dates determine when time- or performance-based conditions are met.
• The overall expiry sets the final date under which the option may be exercised.
• A narrower exercise window may limit when a vested option can be used, including during a post-termination period.
• Administrative cutoffs may require notice, approval or cleared funds before the contractual deadline.

A cliff means that no options vest until a specified service milestone, after which a stated portion may vest. Staged vesting releases options over several periods; performance vesting adds company or individual performance conditions. The agreement determines which applies. There is no universal vesting schedule or option term that can be assumed from the phrase “employee stock option.”

Company restrictions can also separate the right to exercise from the right to sell. Holding the acquired shares and selling them may face different approval, blackout or trading-window requirements. Some plans require company or administrator approval before exercise. Others restrict share transfers or sales even when the option itself is exercisable.

Check these items before submitting an exercise:

1. Confirm the exact grant and its accepted status.
2. Verify the vested or otherwise eligible quantity and any performance conditions.
3. Check the exercise price, valuation method, expiration date and submission cutoff.
4. Confirm whether the chosen method is permitted and whether company approval is required.
5. Make sure the required funds, forms and tax estimates will be available before the cutoff.

The administrator’s instructions are particularly important near expiry. A contract may allow exercise up to a final date, while the practical process requires payment or approval earlier. Obtain the actual deadline and funding requirements in writing rather than relying on a general deadline convention. Published plans illustrate these differences: the NIKE 2025 incentive plan addresses vesting, expiration and exercise, while Fidelity’s stock-option guidance explains plan-specific blackout and submission conditions. Neither source establishes the terms of another company’s grant.

Leaving the company or facing a corporate transaction

Leaving the company can change both your contractual permission to exercise and the tax treatment of a U.S. incentive stock option (ISO). Those are separate questions, so a post-termination exercise window does not by itself preserve favorable ISO treatment.

First determine what happens to each grant. The plan may cancel unvested options while allowing vested options to remain exercisable for a defined period. Other terms may distinguish voluntary resignation, retirement, termination for cause, disability or death. The evidence for a particular leaver category can come from different documents, including the plan, award agreement and administrator instructions.

Request the exact answer for each grant:

• the unvested and vested balances;
• the category that applies to your departure;
• the final contractual exercise date;
• any shorter exercise window that replaces the ordinary expiry;
• the submission and funding cutoff;
• any approval, repayment or repurchase terms; and
• written confirmation of whether the exercise was executed or cancelled.

A plan might state, for example, that a departing employee has 90 days to exercise a vested option. That is a contractual period, not a universal rule. It is also not the same as the U.S. federal ISO employment condition. Under IRC §422, ISO treatment generally requires continuous relevant employment from grant through three months before exercise. The statutory disability provision supplies a separate one-year substitution, while death has its own statutory and plan consequences. Consequently, exercising during an allowed post-termination window can still require tax analysis.

If a corporate transaction is proposed, do not assume that every option accelerates, disappears or becomes cash. The governing award provisions may provide for assumption or substitution of the award, cash or securities settlement, modified vesting terms, conditional acceleration, an earlier exercise right, or termination. The outcome can depend on the transaction and on a qualifying-termination condition. The NIKE 2025 incentive plan illustrates these possible treatments; it does not predict another company’s transaction or set a universal acceleration rule.

Before a departure or transaction closes, compare the contractual deadline with the tax deadlines and ask for the signed plan and transaction documents. A long deadline is not enough if the option will be cancelled on a particular event, and a short deadline is not necessarily a tax disqualification by itself. Obtain the grant-by-grant facts before relying on a generic reminder about resigning.

Early exercise of unvested options

Early exercise is possible only when the plan and grant expressly permit the holder to buy shares before the options vest. Acting before the final expiry is not early exercise if the options have already vested.

Early purchase changes when cash is committed; it does not necessarily change when the shares become unconditional. In some plans, shares bought through early exercise remain subject to the original vesting schedule. If employment or performance conditions are not met, the company may have a repurchase or forfeiture right over those shares. The holder can therefore pay the strike price and bear investment risk while still losing the shares before full vesting.

For example, assume a plan permits early exercise of 1,000 unvested options, each buying one share at a $2 exercise price, and the shares have an $8 fair market value at exercise. Paying $2,000 buys shares with a stated value of $8,000, but that $6,000 difference is not cash profit. The holder has committed $2,000, may owe tax or withholding, and may lose the shares if the applicable conditions fail. The agreement must determine whether the purchase is permitted, which triggers it, whether instalments are allowed, and what repurchase price or timing applies.

Early exercise can also change the tax and holding-period dates relevant to the award. It does not guarantee lower tax, create an immediate sale right or accelerate vesting. Before exercising, check:

• express permission and the eligible quantity;
• whether the acquired shares remain unvested;
• forfeiture or company-repurchase terms;
• cash needed for the strike price, fees, tax and withholding;
• the award’s U.S. tax classification;
• the consequences of a later sale; and
• whether any local-law or cross-border review is required.

U.S. 83(b) election and its deadline

For applicable U.S. service-related substantially nonvested property, an election under IRC §83 can include the value of the transferred property in the transfer year rather than waiting until the property becomes substantially vested. The election generally includes the transfer-date fair market value less the amount paid. It concerns property that has been transferred, not an option that remains merely unexercised.

The election is due within 30 days after the property transfer, subject to the deadline rules in the current IRS Form 15620 instructions. If the holder misses the applicable deadline, the election cannot be made through this procedure for that transfer. A person considering an early exercise should therefore assess the timing before paying, rather than trying to correct the treatment afterward.

The election is not a guarantee of zero tax, and it is not a promise that a forfeiture will produce a refund. It also does not apply the same way to every employee option. An ordinary nonstatutory stock option is generally subject to the restricted-property rules described in IRC §83. For shares acquired through an ISO, the alternative minimum tax analysis is distinct: IRS Form 6251 instructions address the AMT timing and a separate 30-day election for including the ISO transfer-date spread in AMT earlier. The worker should confirm the award’s classification and use the election that applies to that instrument rather than treating an 83(b) election as a universal early-exercise strategy.

How much exercising costs and how to fund it

Strike price, spread, and cash at risk

The minimum exercise payment is the number of options exercised multiplied by the strike price. That payment buys shares; it does not pay the full value of those shares, cover every cost of exercising, or determine the cash received if they are later sold.

Consider a hypothetical grant of 1,000 options with a $2 strike price, assuming each option buys one share. At an exercise-date fair market value of $8 per share:

• Purchase cost: 1,000 × $2 = $2,000
• Value of the acquired shares: 1,000 × $8 = $8,000
• Spread: $8,000 − $2,000 = $6,000

The spread is the difference between the stated share value and the exercise cost on the exercise date. It is not realized profit. No cash has been received unless the shares are sold, and a private company’s fair market value may not equal a price at which the holder can actually sell. Fees, tax or withholding, and any gap between valuation and sale proceeds also affect the result.

The option is “in the money” when the underlying share value exceeds the strike price, “at the money” when they are equal, and “out of the money” when the share value is lower. An underwater option may still be contractually exercisable; it is not necessarily worthless or legally impossible to use. Conversely, zero intrinsic value does not mean an option has no remaining value because time value, vesting and contractual rights can still matter. These relationships are explained in the Options Industry Council’s option glossary and exercise FAQ.

The amount that must be available before exercising is broader than the strike price. Check:

1. Strike cost: quantity × exercise price.
2. Tax or withholding: potentially due because of the exercise, depending on the award and local rules.
3. Fees and commissions: any charges required by the administrator or broker.
4. Funding availability: cleared money in the accepted account and enough time for the required settlement process.
5. Continuing exposure: the possibility that the share value falls before a permitted sale.

Assume the hypothetical company’s shares decline from $8 to $3 after exercise. The holder has paid $2,000 and still holds shares valued at $3,000 on that assumption, leaving a $1,000 paper spread over the strike payment before other costs. That is not cash received unless a sale occurs. If the price falls below $2, the holder may have paid more than the later stated value. If the company fails or the shares cannot be sold when needed, a valuation shown on company records may not provide usable cash.

This is why a private-company option should not be valued by the size of its paper spread alone. Transfer restrictions, company repurchase rights, permitted-buyer rules and the absence of a public market may prevent the holder from converting the shares into the assumed value. The SEC’s overview of private secondary markets explains why a private share can require a lawful transfer pathway and an available buyer.

Before committing funds, compare the exercise payment and expected tax reserve with the cash the holder can retain without relying on a future sale. A larger stated spread does not compensate for cash strain, uncertain liquidity or a falling share price.

Paying cash and holding shares

Paying cash and holding shares separates the funding decision from the decision to sell. In a cash exercise-and-hold, the holder pays the strike price and any required fees, tax or withholding, then retains the acquired shares. Holding them may be the only available outcome if the company shares are illiquid or the holder is not permitted to sell.

Using the earlier hypothetical of 1,000 options with a $2 strike price and an $8 exercise-date fair market value, a cash exercise requires $2,000 for the shares. The holder then owns 1,000 shares with a stated value of $8,000. The $6,000 difference is a paper spread, not spendable cash. The holder may also need separate funds for tax or withholding and fees.

Before paying, ask whether the full outlay leaves enough cash for:

• an emergency reserve and ordinary expenses;
• taxes arising from the exercise;
• fees and future administrative costs; and
• an indefinite period without access to the investment.

Holding employer shares can concentrate risk because the holder’s salary and savings may depend on the same company. The shares can lose value even if the holder never sells them, and they may be difficult to transfer. Those are reasons to assess cash needs and overall exposure, not reasons to predict the company’s future performance.

The payment method and holding period are nevertheless distinct. A plan may permit cash exercise, a broker-assisted exercise, net exercise or another method. Whether the holder receives and keeps the full number of shares, receives fewer shares, or must sell some depends on the selected method and the plan’s withholding, approval and transfer rules. The administrator’s current instructions determine the required account, funding source and processing steps; there is no universal wire or payroll procedure for every employee option plan. Fidelity’s stock-plan guidance illustrates the distinction between exercise-and-hold and exercise-and-sell methods, but the reader’s own plan controls.

Cash exercise and holding are complete only after the plan confirms the acquisition. The holder should retain the exercise confirmation and verify the shares in the company or brokerage record rather than treating a submitted request as proof of ownership.

Selling all shares or selling enough to cover

Selling all the exercised shares and selling only enough to cover costs produce different outcomes. Both require an available buyer and a permitted sale mechanism; “cashless exercise” is an umbrella term, not a promise that every plan offers it or that the transaction produces no tax.

Assume the earlier hypothetical permits an immediate sale of 1,000 newly exercised shares at $8 each. The gross proceeds are $8,000. Suppose the plan requires $2,000 for the strike price, $1,500 of tax funding and $100 in fees. Total funding is $3,600. The $1,500 tax figure is an assumed scenario input, not a statutory estimate or the holder’s actual liability.

Under an exercise-and-sell-all arrangement, the sale proceeds cover those costs and the remaining $4,400 is returned as net cash. The holder ends with no shares from that exercise and therefore gives up any later increase in their value. Actual proceeds can be lower if the sale price changes, only part of the order fills, or additional costs arise.

Under a sell-to-cover arrangement, only enough shares are sold to pay the specified costs. At an assumed $8 sale price:

• $3,600 ÷ $8 = 450 shares sold
• 1,000 − 450 = 550 shares retained

The holder keeps 550 shares, so the exercise does not provide cash for those shares. If their value falls, the holder remains exposed; if their value rises, the holder participates in that increase. The exact quantity can change because the administrator calculates withholding and fees, may round the result, and may sell at a price different from $8.

Caption: Hypothetical: 1,000 options, $2 strike, $8 sale price, $1,500 tax funding and $100 fees. Methods must be allowed; assume full sales at $8. The tax input is assumed, not an estimated liability. Fidelity: Stock plan taxes and filing

Selling all shares therefore trades the entire acquired position for cash, while sell-to-cover funds the exercise and costs but leaves a smaller investment. Neither method guarantees a particular amount of cash because the sale price, exact costs, execution and available liquidity remain uncertain.

For a private company, “sale” may mean a company tender, an approved secondary transaction or another permitted transfer route. An IPO, tender offer or public listing does not automatically make every holder eligible to sell, and a valuation shown on company records does not guarantee an executable price. The holder should confirm who may buy, whether transfers are restricted, whether company approval is required and whether a trading window is open. The SEC’s private secondary markets overview explains the role of transfer restrictions and permitted buyers.

Before choosing a method, ask the administrator to state:

• the shares to be issued, sold and retained;
• the strike payment and required withholding;
• whether any sale order may be partial;
• the price and timing conditions;
• who bears a failed or unfilled sale; and
• the tax records produced by each method.

Cash funding and sell-to-cover solve different problems. The first may preserve the whole position while using the holder’s money. The second raises cash from part of the position to pay for acquiring and exercising it. Neither removes market risk, liquidity risk or tax treatment.

Net exercise, share swaps, and financing

Net exercise, share swaps and financing solve the problem of insufficient cash, but they do not remove the investment or tax consequences of acquiring shares.

With net exercise, the administrator withholds shares that otherwise would have been issued to pay the strike price or required tax withholding. It is not a market sale: no shares are sold to a buyer, and the holder receives fewer shares than the number exercised. The holder needs the administrator’s calculation to determine the exact share count and value retained.

With a share swap, the holder tenders shares already owned to pay part or all of the exercise price. The administrator values the tendered shares and may limit which owned shares can be used. Tendering existing shares uses an existing holding to pay for the new shares; net exercise reduces the new shares delivered. Neither method by itself establishes that the holder’s total share exposure falls.

Ask the administrator to distinguish:

• how the strike price is settled;
• how tax or withholding is settled;
• the valuation applied to tendered or withheld shares;
• the number of shares issued and retained;
• whether transaction costs are charged; and
• which tax records report the exercise.

Caption: NIKE’s 2025 plan illustrates these alternatives. Net exercise reduces shares otherwise issued; a share swap tenders already-owned shares. Permission, valuation and withholding treatment depend on the actual plan. NIKE: 2025 incentive plan, Annex A

Availability depends on the plan, administrator, award terms and local law. The NIKE 2025 incentive plan illustrates how one published plan separates owned-share payment, broker-assisted sale and net exercise. It does not establish that every company permits these methods.

Financing works differently. An employer note, recourse arrangement or external borrowing can provide cash for the exercise while creating repayment obligations. The holder may owe interest or fees, may have collateral at risk and may face a repayment or forced-sale event if the employment relationship or share value changes. Margin borrowing against other investments can also create interest costs and forced-liquidation risk, as the SEC Investor.gov margin bulletin explains. These mechanisms change the financing risk; they do not guarantee a gain or transfer the company’s business risk to the lender.

Before accepting financing, review the actual agreement for:

• recourse or nonrecourse treatment;
• interest, fees and repayment dates;
• repayment triggers;
• collateral and forced-sale provisions;
• whether the plan permits the structure; and
• how repayment interacts with vesting, forfeiture or a tax event.

A financing product marketed as nonrecourse may still create economic obligations that differ from ordinary cash exercise, so its tax and risk treatment needs specific review. The IRS Publication 525 notes the tax treatment of an employer recourse note used to satisfy an option exercise price. Do not describe every financing arrangement as a loan, and do not borrow merely because the method is available.

Compare the funding methods: cash exercise uses money while leaving the full position; net exercise and share swaps reduce the shares delivered or exchanged; borrowing introduces a repayment obligation, while other financing structures require review of their own economic terms. In every case, compare the retained or issued shares with the amount of cash committed, the cost of the funding method and the holder’s ability to bear the shares without relying on a prompt sale.

What tax treatment depends on

U.S. incentive and nonstatutory stock options

The U.S. tax result depends first on what the award is, then on when the option is exercised and what happens to the shares. An incentive stock option (ISO) and a nonstatutory stock option (NSO) are different statutory classifications. The labels “ISO” and “NSO” on a form do not replace the requirements in the award documents.

An ISO requires the holder to meet statutory and plan conditions, including the employment and option-design requirements described in IRC §422. A director, adviser or contractor does not receive ISO status merely because the person is providing services to the company. If the award fails ISO requirements, it may be an NSO. The IRS Topic 427 explains the distinction.

A qualifying ISO exercise generally creates no regular federal income inclusion. That does not mean the exercise is tax-free in every sense: the spread may create an alternative minimum tax (AMT) adjustment, and the later sale can produce a different regular-tax result. If the ISO-acquired shares are disposed of in the same tax year as the exercise, the IRS Form 6251 instructions generally do not require an ISO exercise AMT adjustment for those shares. The disposition still requires its own regular-tax analysis, including whether it is a disqualifying disposition under the ISO holding-period rules. Exercise and sale therefore remain separate events even when they occur in the same year.

An NSO follows different rules. For an ordinary NSO without readily determinable value at grant, compensation generally arises when the acquired property becomes substantially vested. For a typical exercise of vested shares, the compensation measure is generally the acquired shares’ fair market value minus the amount paid. Early exercise of unvested shares requires separate analysis because the shares may remain subject to vesting and forfeiture.

These classifications matter before the holder funds the exercise. The grant, plan, work status, exercise date, withholding estimate and intended sale date should be reviewed together.

ISO holding periods, AMT, and mixed grants

A qualifying ISO sale must satisfy both holding periods:

1. at least two years from the grant date; and
2. at least one year from the transfer of the shares after exercise.

Failure to meet either period can result in a disqualifying disposition with compensation consequences. Meeting both periods satisfies the holding-period test, not every other ISO requirement. The statutory requirements are set out in IRC §422 and summarized by the IRS.

Caption: U.S. federal ISO holding-period test only. Both periods must be met; other ISO conditions still apply. This diagram does not calculate tax: exercise can create an AMT adjustment and regular and AMT bases can differ. U.S. Code: 26 USC 422 · IRS: Instructions for Form 6251

AMT is a separate layer from regular income tax. A qualifying ISO exercise generally produces no regular income inclusion but may produce an AMT adjustment based on the exercise-date spread. Under the Form 6251 Line 2i rule, disposing of the ISO-acquired shares in the same tax year as exercise generally means that no ISO exercise AMT adjustment is required for those shares. This rule addresses the AMT adjustment; it does not determine the regular-tax result of the disposition. A sale before both ISO holding periods are met can still be a disqualifying disposition, and a same-year sale still requires the applicable regular-tax and basis analysis.

AMT is not payroll withholding, and an adjustment does not by itself mean the holder owes tax; the result depends on the whole return. The holder should also keep regular and AMT basis records separate because they need not match.

The $100,000 ISO limit measures the aggregate grant-date fair market value of the underlying shares for options that first become exercisable in a calendar year across the relevant employer-group plans. It is not a limit on the cash spent to exercise, a limit measured at exercise-date value, or a cap that resets merely by waiting. Options are counted in grant order, and the excess is non-ISO.

For example, assume two otherwise qualifying grants, each covering shares with a grant-date fair market value of $75,000, first become exercisable in the same year under the same employer-group plans, with no other relevant grants. Their combined value is $150,000, so $50,000 falls outside the ISO limitation. Under the ordering rule, that excess belongs to the later grant. The result does not reveal how many options are affected unless each grant’s per-share value is known. See IRC §422(d).

Mixed grants need separate records. One grant may remain ISO while an excess portion of another is NSO, and the two classifications can produce different exercise, AMT and later-sale treatment.

NSO income and withholding

For an ordinary NSO, compensation generally depends on the option’s value and the vesting status of the acquired property. If a holder exercises shares that are already substantially vested, the exercise-date compensation is generally the shares’ fair market value minus the price paid. If the shares remain substantially unvested, the ordinary treatment may defer compensation until vesting, subject to the restricted-property rules. A grant with readily determinable value can require a different analysis again.

Employee NSO compensation is generally subject to employment and income-tax withholding and is reported through the employee compensation reporting process, commonly the W-2. A nonemployee’s award follows the applicable nonemployee reporting route rather than automatically following the employee W-2 treatment. The IRS Topic 427 explains the compensation-versus-sale distinction; Publication 525 provides the sale and basis rules.

Withholding is a prepayment, not the holder’s final tax liability. The holder must retain the exercise-date fair market value, amount paid, compensation included, tax withheld and any later sale record. An administrator’s estimated tax figure can help budget the exercise, but it does not resolve the final tax treatment or determine the gain on a later sale.

The key timing distinction is this:

• At exercise: an NSO may create compensation and withholding, while a qualifying ISO exercise generally has no regular income inclusion but may create an AMT adjustment.
• At sale: the holder applies the award’s sale and basis rules. Exercise compensation and sale gain are different items and must not be combined or confused.

U.K. share option schemes

A U.K. option should be assessed under the scheme that governs it, not by importing U.S. ISO and NSO rules. The relevant distinction is between tax-advantaged schemes—EMI, CSOP and SAYE—and non-tax-advantaged share arrangements. Each has its own agreement, eligibility and tax conditions.

The GOV.UK overview of tax and employee share schemes explains that the scheme type determines whether tax advantages apply. Exercise relief, employment-income and National Insurance treatment, and the tax treatment of a later sale are separate questions. A later sale can produce a capital-gains event even when exercise received relief.

For EMI, current GOV.UK EMI guidance conditions exercise relief on requirements including payment of at least the grant-date market value and exercise within the agreement’s 10- or 15-year period. The applicable period depends on the agreement; it is not accurate to describe every EMI grant as having a universal ten-year term. Discounted grants, employee circumstances and later disposal events can change the analysis, so the current scheme rules and agreement must be checked.

For CSOP, current guidance calls the scheme the Company Share Option Plan and also uses the term EMI2. Its normal qualifying route described by GOV.UK involves buying shares between three and ten years after the offer, with possible capital-gains tax on a later sale. This is an illustration of the ordinary route, not a statement that every historical grant or exceptional event follows identical treatment.

For SAYE, the holder builds savings tied to a fixed-price purchase. The GOV.UK SAYE guidance describes Income Tax and National Insurance relief in relation to the exercise spread, while a later sale can be a separate taxable event. Those savings mechanics should not be transferred to EMI, CSOP or an employee option in another jurisdiction.

A non-tax-advantaged arrangement may instead create taxable employment income or National Insurance consequences at exercise, subject to its terms and the facts. The label “share option” does not establish that relief applies.

Before exercising, check:

• the scheme named in the option agreement;
• whether the holder and grant meet its current conditions;
• the agreement’s exercise period and any relevant amendments;
• the exercise price and any discount;
• the expected payroll or National Insurance treatment;
• restrictions on selling or transferring the shares; and
• the treatment of a later sale or disqualifying event.

The issuer’s country and the language of a search result do not determine the holder’s tax result. A U.K. employee, a worker employed in the U.K. by a foreign company, and a cross-border employee may require different reviews. The holder should use the current GOV.UK scheme guidance and obtain advice based on the actual agreement rather than assume that an option labelled “ISO” or “EMI” receives a universal outcome.

German and cross-border considerations

German and cross-border option exercises cannot be resolved by the option’s label or by applying U.S. ISO and NSO rules. First establish what the holder actually receives, then review the tax treatment in each relevant jurisdiction.

An employee share-purchase option can lead to the delivery of company shares. A cash-only virtual award produces a cash payment rather than delivering shares. That distinction is necessary, but it does not by itself determine German tax treatment. Similarly, an award classified as an ISO under U.S. law may still raise German employment-income, payroll, withholding or reporting questions.

For Germany, §19a of the German Income Tax Act provides conditional employment-income treatment for specified free or discounted equity transfers made in addition to salary. It depends on statutory conditions concerning the transfer, employer and company. Calling an award an “option,” or describing an exercise as early, does not establish that those conditions are met.

Where §19a applies, payroll treatment is especially important. Under §19a(2), provisional non-taxation through payroll withholding requires the employee’s consent. If that treatment is omitted, the statute states that the provisional non-taxation cannot subsequently be made up in the personal income-tax assessment. This is not a general prohibition on amending a return, but it means a worker cannot assume that omitted treatment will be repaired later.

Caption: Germany: §19a is conditional on a qualifying equity transfer and statutory company conditions. Employee consent is required in payroll; omitted provisional non-taxation cannot be caught up in personal assessment. Deferred tax has later triggers. German statute: EStG section 19a

Before an exercise involving Germany, ask the employer, payroll team or a German adviser to verify:

1. Whether the transaction is a qualifying equity transfer under §19a.
2. Whether the employer and company meet the relevant statutory conditions.
3. Whether employee consent has been obtained.
4. Whether payroll will apply provisional non-taxation correctly.
5. Which records must support the treatment.
6. Which later event may trigger deferred tax.

§19a defers covered wage taxation; it does not permanently exempt it. Later statutory triggers can include the transfer, the passage of the statutory period or the end of employment, subject to the detailed rules and any relevant employer undertaking. It should not be presented as a “tax only on sale” rule.

For a cross-border holder, the relevant facts include:

• residence and work locations during the award period;
• the grant, vesting, exercise and sale dates;
• where each taxable or reportable event occurs;
• the issuer, employing entity and administrator;
• the instrument’s terms and settlement method; and
• any applicable withholding, payroll and double-tax-relief process.

These facts identify the questions for local review; they do not create a universal allocation formula. HMRC’s employment-related securities manual similarly treats domestic law and treaty effects as separate checks based on the employee’s circumstances. Neither a treaty nor a local deferral should be assumed merely because the employer, issuer or worker is internationally mobile.

Before submitting the exercise, the holder should obtain answers to four practical questions:

• Which country’s rules apply to each grant, vesting, exercise and sale event?
• Is tax withholding or payroll reporting required?
• Does any transfer relief actually apply, and has the required consent and administration been completed?
• What records will the employer and administrator retain?

If a German exercise may involve a qualifying §19a equity transfer, check eligibility, employee consent and payroll implementation before relying on that treatment. For a cross-border award, local advice should cover the holder’s actual residence, work history and award dates. Neither the issuer’s location nor a U.S. tax classification answers those questions by itself.

How to weigh exercising now against waiting

Private-company liquidity and company risk

Private-company shares may have a stated fair market value while offering little practical liquidity. Before exercising, treat the shares as an investment that could become worth less—or nothing—and determine whether the holder can convert them into cash when needed.

Three questions need separate answers:

1. What is the stated value? Fair market value is a valuation input used for exercise, accounting and tax purposes.
2. Can the holder sell? A lawful transfer route, permitted buyer, company approval and trading restrictions determine practical liquidity.
3. What risks remain after purchase? The holder continues to bear price, business and concentration risk while holding the shares.

Private securities may be subject to contractual resale restrictions, company approval requirements and other legal limits. The SEC’s overview of private secondary markets explains why a private sale requires a permitted pathway and an available buyer. A company tender, private secondary transaction or IPO may create a possible route, but none guarantees that a particular holder is eligible, that the transaction will occur, or that shares can be sold at the stated valuation.

Suppose the holder can pay $2,000 to exercise 1,000 options and the shares have a stated value of $8,000. If no permitted sale is available, the holder has $2,000 of cash tied to an illiquid position and no $6,000 cash gain. If the company later fails or the valuation falls, the holder can lose the strike payment and the remaining value. If a permitted buyer exists at $8, the situation differs because the stated value becomes executable cash—but only for that permitted transaction and at its actual terms.

The timing of an IPO or tender therefore matters less than whether the holder has an actual eligible route. An announced or possible IPO does not guarantee a date, price or immediate tradability. A tender may exclude a holder or apply different prices and conditions. A company repurchase right may be limited or subject to the company’s discretion rather than guaranteed redemption at fair market value.

Exercising also concentrates financial exposure on one employer. If the holder keeps both salary and shares, a decline in the company can affect income and investments together. Familiarity with the business may also make it easier to underestimate risks that appear obvious to an outside investor. The relevant response is not a universal portfolio percentage; it is a review of cash needs, existing exposure and the ability to withstand a decline or an illiquid holding period.

A share count does not establish a fixed ownership percentage. New share issuance can dilute a holder’s proportional ownership, and common and preferred shares may carry different voting, dividend and liquidation rights. The holder should ask for the share class, the current total share denominator and any adjustment or anti-dilution terms that actually apply. The SEC glossary explains dilution, while Investor.gov’s stock guidance describes the differences among share classes.

The comparison is therefore between two cash positions: exercise uses cash now and leaves the holder holding an uncertain investment; waiting preserves the cash but may surrender the current spread, change the tax timing or allow the option to expire. For a private company, the inability to sell can be as important as the reported value. Ask whether a permitted buyer and transfer route actually exist before treating an exercise as equivalent to receiving cash.

Timing, tax scenarios, and staged exercises

Compare exercise now, later, in stages and not at all using the same set of facts: expiry, cash committed, tax timing, holding conditions, liquidity and the shares still exposed. The best-looking maximum gain is not a useful comparison if it assumes a sale that cannot occur or ignores money the holder must retain.

A staged exercise can change when cash is spent and how many options remain. Under the earlier hypothetical, exercising 250 of 1,000 eligible options at a $2 strike commits $500 and leaves 750 options outstanding, assuming partial exercise is permitted. The holder receives 250 shares, not a promise of the full grant, and must still satisfy taxes, fees and any restrictions. Splitting an exercise across dates can reduce the amount committed on one date, but it does not automatically lower total tax, create a better price or reduce investment risk. Each date may also have its own valuation, withholding and holding-period facts.

A sound comparison should show, for each scenario:

• cash paid for the strike price;
• additional tax or withholding and fees;
• shares acquired and shares retained;
• the exercise and acquisition dates;
• the remaining option balance and expiry;
• the tax event triggered at each stage;
• the earliest permitted sale and any liquidity restriction; and
• proceeds after costs under plausible sale assumptions.

Use the actual grant dates rather than generic windows. A delay may preserve cash, but it can also move the exercise into a different tax year, change the spread, reduce the remaining life of the option or eliminate it at expiry. Waiting can avoid an immediate exercise tax, but it cannot preserve a right after the contractual deadline.

For a qualifying U.S. ISO, sale treatment requires both the two-year period from grant and the one-year period after share transfer under IRC §422. A same-year sale after exercise can also change the AMT analysis. Exercise-and-hold can therefore produce a different result from a quick sale, but holding does not guarantee a favorable result if other qualification requirements fail.

AMT is a cash-timing issue as well as a return issue. A prior-year minimum-tax credit may be available for AMT attributable to qualifying deferral items, but IRS Form 8801 instructions show that the credit is conditional and subject to limitations and carryforward rules. It is not an instant refund or a guaranteed recovery in the exercise year.

Separate sale benefits from exercise benefits. The U.S. qualified-small-business-stock exclusion in IRC §1202 has its own issuer, stock, acquisition-date and holding requirements. Exercising an option does not establish eligibility, and current law includes different holding tiers. The practical decision is to ask a tax adviser to verify eligibility rather than treat the exclusion as an automatic reason to exercise.

A useful adviser should understand the specific option, the company’s liquidity, the holder’s cross-border circumstances and the holder’s overall finances. Ask for scenarios rather than a prediction of an IPO, market bottom or company outcome. The adviser can compare after-cost cash and retained exposure, but cannot guarantee a return, liquidity or tax result.

Compare the four outcomes:

• Now: more cash committed, earlier tax timing and greater current exposure.
• Later: less cash committed today, but expiry, changed valuation and potentially different tax timing.
• Partially: lower cash committed at one exercise date and a smaller acquired position, with a remaining option balance.
• Not at all: the holder commits no exercise cash and acquires no shares or shareholding exposure from these options, but forfeits the opportunity if the right expires unexercised.

Base that comparison on the actual grant, local tax rules and a lawful liquidity path. If the holder cannot explain how shares would be sold or how cash would be recovered without straining personal finances, the stated spread alone does not resolve the decision.

What to check when submitting and after exercising

Submit the correct grant and confirm completion

To verify completion, obtain confirmation that the selected options were exercised under the plan and reconcile the resulting share record and any sale proceeds. A preview, submitted request or pending order shows that an instruction was entered; it does not by itself prove completion.

Before submitting, verify the following against the current plan and administrator instructions:

1. The correct grant: the accepted award, grant date, option type and any amendments.
2. The eligible quantity: vested or otherwise exercisable options, including unvested options only where early exercise is expressly permitted, and excluding any ineligible quantity.
3. The price and valuation: the strike price, exercise-date fair market value and the administrator’s valuation method.
4. The selected method: cash exercise, exercise-and-hold, exercise-and-sell, sell-to-cover, net exercise or another permitted route.
5. The cash position: the strike cost, taxes or withholding, fees and cleared funds in the required account.
6. The deadline and approvals: the contractual expiry, submission cutoff, company approval and required forms.
7. The sale instructions: any price limit, order condition, permitted buyer or trading window.

If a sale is part of the request, separate the exercise from the sale. A broker-linked order may fill in part or at different prices. A cancellation request is also not proof that the transaction was cancelled: the administrator must confirm that the exercise or sale was actually stopped before execution. Fidelity’s stock-option guidance illustrates these distinctions, but its interface, cutoffs and processing steps are not universal.

Caption: Operational checks, not a universal platform sequence or settlement schedule. Verify actual administrator cutoffs and execution records. For broker-linked sales, a cancellation-request confirmation does not prove cancellation. Fidelity Private Shares: How to exercise options · Fidelity NetBenefits: Exercise confirmations · NIKE: 2025 incentive plan, Annex A

After submitting, check the administrator’s status and retain the unique confirmation. Look for the states that matter:

• Preview: the proposed transaction has not yet been submitted.
• Submitted or pending: the instruction has been received but may not have executed.
• Executed: the exercise or sale has completed under the administrator’s records.
• Issued or recorded: the shares appear in the holder’s share or brokerage record.
• Proceeds recorded: the cash from a sale appears in the relevant account.
• Cancelled: the administrator confirms that the transaction did not execute; a cancellation request alone is insufficient.

Near a deadline, obtain written confirmation of the cut-off, funding and processing requirements. Do not assume that an option can be exercised instantaneously or that a submitted request will be completed before expiry. A plan may require payment or approval before its final date. The NIKE 2025 incentive plan, for example, illustrates a process in which notice, payment and required withholding precede issuance; other plans can differ.

Retain more than a screenshot of the order form. The confirmation should identify the grant, quantity, strike price, exercise date, payment, method, fees or withholding, and any sale terms. Cross-check it against the shareholding or cash record and keep all approval messages.

If the expected confirmation does not match the transaction, escalate before assuming the exercise occurred. Check whether the request is pending, rejected, partially executed or cancelled, and ask the administrator to reconcile the grant balance and payment. The important distinction is simple: submission starts a process, while confirmation of execution and the resulting ownership or proceeds record establishes that the exercise happened.

Retain records and reconcile tax basis

Exercise compensation and later sale gain are separate tax calculations. The exercise records establish what was paid, what value was received and what compensation was already included; the sale records show what was later sold and for how much. Reconciling the two prevents strike-only cost from being mistaken for complete tax basis.

Keep the governing documents and transaction records together:

• the plan, award agreement and amendments;
• grant, vesting and exercise dates;
• the number of options exercised and shares acquired;
• the strike price and exercise-date fair market value;
• cash paid, fees, compensation and withholding;
• the administrator’s exercise confirmation;
• the shareholding or cap-table record; and
• the later sale confirmation and sale proceeds.

Different U.S. records serve different purposes. IRS Form 3921 instructions identify the grant date, exercise date, exercise price, exercise-date fair market value and number of shares transferred for an ISO transfer record, subject to the form’s exceptions. Employee NSO compensation may instead be reported on the employee’s W-2. A broker’s sale statement reports the sale and its reported cost basis; it does not replace the exercise records or compensation record. Not every holder receives every form, so the holder should reconcile the documents that apply to the award and year.

For post-2013 compensatory-option and equity awards, a broker generally cannot increase the initial basis it reports by compensation income recognized at exercise. Under the 2026 Instructions for Form 1099-B, that reporting restriction does not remove compensation basis from the taxpayer’s calculation. In other words, a broker’s strike-only reported basis can be incomplete where compensation was already included in income.

Consider an ordinary U.S. NSO example:

• 100 vested shares are acquired for a $5 strike price, so the holder pays $500.
• Their exercise-date fair market value is $15 per share, giving a total share value of $1,500.
• The compensation included in income is therefore $1,000.
• The holder’s regular basis before other adjustments is $500 + $1,000 = $1,500.
• A later sale for $1,800 before fees produces an illustrative gain of $1,800 − $1,500 = $300.

Using only the $500 strike cost would instead suggest a $1,300 gain and omit the $1,000 already included in compensation income. The IRS Publication 525 guidance on NSOs explains that the amount paid plus compensation included forms the basis and addresses the reporting mismatch for awards granted from January 1, 2014, including the need for an applicable Form 8949 adjustment.

Caption: U.S. hypothetical ordinary vested NSO: 100 shares, $5 strike, $15 exercise FMV, $1,000 compensation included. No grant-time income, fees or other adjustments. Broker-reported basis can omit compensation; this is not an ISO/AMT formula. IRS: Publication 525, Sale of the stock · IRS: 2026 Instructions for Form 1099-B

The example assumes an ordinary vested-share NSO, no grant-time income, no fees and no other basis adjustments. It is not an ISO formula. For an ISO, regular tax and AMT basis can differ, and exercise may create an AMT adjustment rather than the NSO compensation shown above. The IRS Form 6251 instructions explain those separate records.

Before filing, compare the broker statement, compensation record and exercise confirmation. If the reported basis omits compensation already included, ask a tax adviser whether an adjustment is required for the specific year and award. Do not apply the $300 or $1,300 example mechanically to another grant: the correct result depends on the option type, actual compensation, exercise and sale dates, holding conditions and any other adjustments.

What HR and finance should explain

HR and finance should explain the award’s rules, the available exercise process and who will confirm each outcome. They should not advise employees on whether exercising is financially or tax-wise preferable, promise a profit, or state that every option follows the same deadlines.

The company should give each holder the documents and information needed to act:

• the controlling plan and grant agreement;
• the grant date, type, strike price and current eligible balance;
• the vesting, expiry and any post-termination exercise dates;
• performance conditions and company approvals;
• permitted exercise, sale, net-settlement and financing methods;
• fees, valuation method, cash requirements and tax-withholding inputs;
• blackout, transfer and trading restrictions;
• submission cutoffs, funding deadlines and the administrator’s process;
• the responsible contact for questions; and
• what confirmation will establish completion.

These details must come from the holder’s actual grant and current plan. A generic statement such as “exercisable for 90 days after leaving” is insufficient because the period may differ by grant, leaver category and event. It may also be confused with the separate U.S. ISO employment condition. For someone preparing to leave, HR should provide a grant-by-grant statement of the final exercise date, eligible quantity and required process, with the applicable tax-status question referred for local advice.

Exercise administration and investment advice should remain separate. The company can explain how much cash is required, which methods are available and what records will be produced. It should not choose the holder’s funding method, recommend selling, predict a future share price or promise tax savings. If the employee needs help choosing among scenarios, that is a question for an adviser experienced in the relevant option type and jurisdictions.

After completion, the company’s records should match the transaction. Finance should be able to reconcile the exercise confirmation, cash received, shares issued, resulting shareholder or cap-table entry, payroll entries and tax reporting. The administrator’s confirmation should identify the grant, quantity, exercise date, strike price, payment, withholding and method. Any sale record should be reconciled separately.

Reporting also depends on the award and jurisdiction. In the U.S., employee NSO compensation is generally included in employee compensation reporting, while an ISO transfer may require a Form 3921 record under its applicable rules. In Germany, if the conditional §19a treatment applies, the payroll records required by the statute also need to reflect the treatment applied. These are different records; a platform feature or administrator workflow does not itself establish legal compliance or replace the company’s review.

Communications should include:

1. The employee’s exact grant-specific deadline and available quantity.
2. The administrator’s exercise instructions and funding requirements.
3. The company and administrator contacts for operational questions.
4. A clear statement that local tax advice may be needed.
5. Confirmation of completion and the resulting share or proceeds record.
6. Any payroll or tax documents relevant to the holder’s award.

HR should also confirm that contact and home addresses remain current, especially during a leaver process. Otherwise, a valid exercise instruction or confirmation may never reach the holder. The Fidelity Private Shares exercise guidance illustrates a workflow involving grant selection, payment, company approval and issued shares. It is one administrator’s process, not a universal standard.

The company’s responsibility is to administer the transaction accurately and supply the governing facts. The holder remains responsible for deciding whether and how to exercise.